India to Chile: Salmeterol Export Trade Route

The India to Chile Salmeterol corridor is one of India's established pharmaceutical export routes, with 242 shipments documented worth a combined $9.7M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 32% of all export value, reflecting the consolidated nature of India's salmeterol manufacturing sector.

Across 7 active suppliers, the average shipment value stands at $40.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during January–March, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 16.7%, placing it at rank #2 among India's top salmeterol export destinations globally.

On the import side, key buyers of Indian salmeterol in Chile include LABORATORIOS RECALCINE SA.., TO THE ORDER OF, SEVEN PHARMA CHILE SPA and 20 others. LABORATORIOS RECALCINE SA.. is the single largest importer with 54 shipments valued at $1.7M USD.

India's salmeterol exports to Chile are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 97 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Chile benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, HETERO LABS LIMITED, HETERO LABS LIMITED — together account for 81% of total trade value on this route. The average shipment value of $40.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as flusacort sf 25/250 salmeterol 25mcg + f and aurituss inhaler (25/250) (salmeterol xinafoate 25mcg + fluticasone propionate 250mcg (1x120 md), suggesting that buyers in Chile tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, LABORATORIOS RECALCINE SA.. is the largest importer with 54 shipments worth $1.7M USD — representing 18% of all salmeterol imports from India on this route. A total of 23 buyers are active on this corridor.